Evotec stock: JPMorgan reports 6.54% total position

Published on 10/29/2026 at 17:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock is in focus after JPMorgan disclosed a changed combined voting position. Evotec will publish nine-month results and a business update on November 5.

Ownership change and next catalyst

The notification was published on October 29, while the threshold event occurred on October 23.
The disclosed position combines voting rights attached to shares with positions held through instruments.
Evotec is scheduled to publish its first nine-month results and provide a business update on November 5.

Evotec SE, DE0005664809, Illustration mit AI erstellt.

What has changed since our last report: JPMorgan Chase & Co. reported a combined position of 6.54% in Evotec on October 29, according to the Deutsche Boerse. The threshold was crossed on October 23, so the publication date and the underlying event date are separate.

The notification lists 3.86% of voting rights attached to shares and 2.69% through instruments. The previous notification showed a combined position of 5.64%. The filing identifies JPMorgan Chase & Co. as the notifying legal entity and describes the disclosure as a voluntary group notification with a threshold triggered at subsidiary level.

Results remain the next test

Evotec has scheduled its first nine-month 2026 results and a business update for November 5. The company said the conference call will be held in English, with the webcast scheduled for 2:00 p.m. CET. The upcoming release will give investors the next formal update on operating performance after the preliminary nine-month figures and unchanged full-year outlook reported earlier in October.

Share price and trading context

At 16:11 Berlin time on October 29, Lang & Schwarz quoted Evotec at EUR 2.94, with a bid of EUR 2.93 and an ask of EUR 2.95. The verified Xetra close on October 28 was EUR 2.97 in euros, according to Global Banking & Finance Review; the current quote is therefore 1.01% below that prior-session close. Compared with the EUR 2.87 quote in our October 28 pre-market report, the L&S price is 2.44% higher. These are separate comparisons and do not establish a causal link between the ownership filing and the share-price movement.

For a live update, see the real-time quote of Evotec stock.